Lantern Pharma Inc.
LTRN
Positions held
Your positionsLTRN isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $12.40M | Enterprise value | $3.29M | Trailing P/E | — | Forward P/E | -0.41 |
| PEG | — | Price / book | -3.29 | Beta | 2.32 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -4.0% | ROA | -74.3% | Debt / equity | — |
| Current ratio | 1.96 | Free cash flow | -$8.24M | Analyst recommendation | none | Mean target | $17.50 |
| 52w high | $4.68 | 52w low | $0.83 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$7.1M | -$3.3M | -$4.1M | -$4.2M | -$4.3M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$3.5M | -$3.4M | -$4.2M | -$4.3M | -$4.7M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$17.1M | -$20.8M | -$16.0M | -$14.3M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$18.0M | -$22.2M | -$17.9M | -$14.4M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · What Could Go Wrong With Recursion Pharmaceuticals Stock?
2026-10-08 · Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026
2026-10-08 · Lantern Pharma secures Taiwan clearances for Phase II NSCLC study
2026-09-30 · Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering
2026-09-29 · Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering
2026-09-22 · Lantern Pharma Secures USPTO Notice of Allowance for LP‑284 Treatment Patent in Aggressive B‑Cell Lymphomas
Price (daily)
Full chart · RSI · MACD · patterns